GFLT 8-K/A
GenFlat Holdings, Inc. (GFLT)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter) |
|
| |||
(State or other jurisdiction of |
| (Commission File Number) |
| (I.R.S. Employer |
| ||
(Address of principal executive offices) |
| (Zip Code) |
Registrant's telephone number, including area code:
_______________________________________________
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act: None
Title of each class | Trading Symbol(s) | Name of exchange on which registered |
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company |
|
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
EXPLANATORY NOTE
On December 21, 2021, Healthcare Business Resources Inc. (the “Company”) filed with the Securities and Exchange Commission (“SEC”) a Current Report on Form 8-K (“Initial Form 8-K”) to disclose that it had dismissed Marcum, LLP (“Marcum”) as its independent registered public accounting firm and appointed B F Borgers CPA PC as its new independent registered public accounting firm.
The Company provided Marcum with a copy of the disclosures it made in the Initial Form 8-K and requested that Marcum furnish a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the statements made therein and, if not, stating the respects in which it does not agree. This Form 8-K/A amends the Initial Form 8-K solely to include copy of Marcum’s letter, dated December 21, 2021, which is filed as Exhibit 16.1 to this Form 8-K/A.
Except as described above, all other information in the Initial 8-K remains unchanged.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits:
Exhibit No. |
| Description |
| ||
104 |
| Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document |
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HEALTHCARE BUSINESS RESOURCES INC. |
| ||
|
|
|
|
Dated: December 23, 2021 | By: | /s/ Stephen Epstein |
|
| Name: | Stephen Epstein |
|
| Title: | Chief Executive Officer and Chief Financial Officer |
|
3 |
EXHIBIT 16.1
December 21, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Healthcare Business Resources Inc. under Item 4.01 of its Form 8-K dated December 21, 2021. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Healthcare Business Resources, Inc. contained therein.
Very truly yours,
Marcum LLP
